umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease
Show others and affiliations
2010 (English)In: Clinical neuropharmacology, ISSN 0362-5664, E-ISSN 1537-162X, Vol. 33, no 5, 260-264 p.Article in journal (Refereed) Published
Abstract [en]

Pridopidine shows promise as a treatment for some of the symptoms of HD. In this small-scale study, the most notable effect was improvement in voluntary motor symptoms. Larger, longer-term trials are warranted.

Place, publisher, year, edition, pages
2010. Vol. 33, no 5, 260-264 p.
Keyword [en]
ACR16, dopaminergic stabilizer, Huntington's disease, pridopidine, randomized clinical trial
Identifiers
URN: urn:nbn:se:umu:diva-42294DOI: 10.1097/WNF.0b013e3181ebb285PubMedID: 20616707OAI: oai:DiVA.org:umu-42294DiVA: diva2:409089
Available from: 2011-04-07 Created: 2011-04-07 Last updated: 2017-12-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Loutfi, GhadaSvenningsson, Anders
By organisation
Neurology
In the same journal
Clinical neuropharmacology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 123 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf